AJR 2005; 185:154-159
© American Roentgen Ray Society
MRI of Sarcoidosis Patients with Musculoskeletal Symptoms
Sandra L. Moore1,
Alvin Teirstein2 and
Cornelia Golimbu1
1 Department of Radiology (Musculoskeletal), NYU Medical Center, 560 First Ave.,
New York, NY 10016.
2 Department of Pulmonary and Critical Care Medicine, Mount Sinai Medical
Center, New York, NY.
Received February 19, 2004;
accepted after revision September 23, 2004.
Address correspondence to S. L. Moore
(sandra.moore{at}med.nyu.edu).
Abstract
OBJECTIVE. Our objective was to determine MRI findings in
sarcoidosis patients with musculoskeletal symptoms.
CONCLUSION. In sarcoidosis patients with musculoskeletal complaints,
MRI reveals marrow and soft-tissue lesions that are occult or underestimated
on radiographs. Axial and large-bone lesions may resemble osseous metastases
on MRI. Most lesions detected are nonspecific in appearance, except nodular
muscle lesions. MRI reveals features suggesting the diagnosis, but with
standard protocols, no pathognomonic MRI features were determined.
Introduction
Sarcoidosis is an inflammatory granulomatous disease of unknown
cause that can involve the muscles, joints, and bones. Musculoskeletal
involvement can be symptomatic or asymptomatic. In the radiographic
literature, it has been emphasized that most skeletal lesions are seen in the
small bones of the hand and feet, usually associated with skin lesions.
Descriptions of MRI findings of large-bone sarcoidosis are primarily in case
reports, more often of the spine
[1-7]
than the appendicular skeleton
[8-13].
The MRI appearance of sarcoid muscle lesions has been described in
retrospective studies [14,
15]. Although osteoarticular
complaints are common among sarcoidosis patients, imaging often is limited to
a negative radiograph, a radiograph showing a classic lacy pattern of
osteolysis in the digits, or, rarely, a lytic or sclerotic large-bone lesion.
Axial skeletal and long-bone involvement are not common radiographic findings
[16]. Neither a bone scan nor
a skeletal survey reliably predicts the location of sarcoidal bone lesions
except in the small bones of the hands and feet
[17].
To our knowledge, no prospective studies have been performed evaluating MRI
for musculoskeletal symptoms in sarcoidosis patients. We hypothesized that MRI
can improve the detection of lesions in sarcoidosis patients with
musculoskeletal complaints.
Subjects and Methods
A prospective study was performed over a
-year period with 42
consecutive patients referred for MRI by the pulmonologists at a
hospital-based sarcoidosis clinic, on the basis of sarcoidosis diagnosis and
unexplained musculoskeletal complaints. Musculoskeletal complaints were
defined as local pain, weakness, and/or extratruncal swelling or mass of
unexplained clinical cause, with no history of recent trauma. Institutional
review board approval was obtained and informed consent signed.
Of 42 patients referred for MRI, in all but three cases, the diagnosis of
sarcoidosis was proven before the MRI evaluation by a positive Kveim-Siltzbach
test (12 patients) or fiberoptic bronchoscopy (12 patients), or biopsy of lung
(one patient), lymph node (four patients), muscle (two patients), bone (one
patient), skin (nine patients), or lacrimal gland (two patients); or a
combination of these methods, revealing noncaseating epithelioid granulomas in
the absence of known granulomagenic agents. One patient with radiographic and
clinical findings of Löfgren's syndrome did not undergo biopsy. Two
patients originally considered likely to have sarcoidosis on clinical grounds
underwent MRI scanning but subsequent biopsy results were inconclusive for
sarcoidosis and they were excluded from the study. Thus, a total of 40
patients were evaluated. The age range of the study subjects was 35-71 years,
with a mean age of 49 years. The duration of disease from establishment of
sarcoidosis diagnosis ranged from less than 1 year to 39 years, with an
average duration of 8.2 years. In the study population, 35 patients (88%) had
intrathoracic disease, 13 patients (33%) had involvement of three or more
organ systems, and 15 patients (38%) had cutaneous sarcoid lesions.
The patients had chest radiographs for evaluation and staging of
intrathoracic involvement (staged according to Mitchell and Scadding
[18]), and laboratory analysis
of serum calcium, alkaline phosphatase, and serum angiotensin-converting
enzyme (ACE). Patient demographics, clinical laboratories, and Scadding stage
are presented in Table 1. For
all of the subjects with clinical or imaging evidence of joint disease,
serology for antinuclear antibodies (ANA) and rheumatoid factor was
obtained.

View larger version (114K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1 38-year-old woman with pulmonary sarcoidosis and hand and
foot deformities. Axial proton density-weighted image (TR/TE 4,016/15) shows
diffuse, poorly marginated marrow infiltration of both calcanei. Patient also
had MRI findings of tendinosis and tenosynovitis of ankle (not shown).
|
|
MR images were obtained using a 1.5 T magnet (Signa Horizon or LX, GE
Healthcare). The area scanned was selected on the basis of signs and/or
symptoms. For patients with the complaint of weakness (in the proximal lower
extremities in all four cases), the symptomatic area was scanned, and studies
for disk pathology or other remote causes were not obtained. A total of 56 MRI
scans were obtained on 40 patients (with 12 bilateral parts, four patients
with scans of more than one extremity). The parts scanned were pelvis/hips (13
patients), hands (13 patients), legs (eight patients), hips (two patients),
feet/ankles (nine patients), shoulder/scapula (four patients), head (three
patients), knee (three patients), and elbow/radius (one patient). Protocols
for the sequences varied by body part imaged and coil selection. Conventional
spin-echo and/or fast spin-echo techniques and inversion recovery and
fat-suppressed proton density and/or T2-weighted fast spin-echo sequences were
used. For the pelvis and lower extremity lesions, the field of view was
enlarged for bilateral assessment. When a masslike lesion was suspected
(n = 6), to determine whether the lesion was solid or cystic, IV
gadolinium chelate was administered and a fat-suppressed T1-weighted pulse
sequence used.
Image Evaluation
Two musculoskeletal radiologists independently reviewed the MR images. At
the time of MRI review, the reviewers were aware that the patients had the
clinical diagnosis of sarcoidosis, but were not aware of the laboratory or
radiographic findings. For each case, the radiologists noted the presence or
absence of and distribution and location of bone lesions, muscle lesions,
soft-tissue masses, soft-tissue infiltration, and/or joint pathology. The two
reviewers' interpretations were in complete agreement in 38/40 (95%) of the
cases and, in two cases, the final agreement was based on consensus after
discussion.
The criterion used for the diagnosis of marrow infiltration was
intramedullary signal alteration compared with the adjacent fatty and/or
hematopoietic marrow. Differentiation of bone lesions from red marrow
deposition was based on morphology (e.g., multiple, discrete cannonball-like
foci not characteristic of marrow replacement vs patchy areas more
characteristic of red marrow), location (not characteristic, such as proximal
phalanges, vs characteristic of red marrow residua, such as the proximal
femurs). The lesions were described as confined to the medullary space versus
with extraosseous extension, and as violating the cortex or not. Determination
was made as to whether the lesions were solitary or multiple, focal or
diffuse, and distinctly or vaguely marginated. Assessment for avascular
necrosis (AVN) was made by established criteria
[19]. Findings considered
diagnostic for joint involvement on MRI included synovitis, tenosynovitis,
effusions, marrow edema at articular margins, and/or subchondral cysts or
erosions. Muscle abnormalities were divided into three groups: fatty
replacement of muscle, edema of muscle, and masslike lesions within the muscle
compartments [20]. Fatty
infiltration was determined on T1-weighted pulse sequences as focal or diffuse
replacement of the muscle with fat compared with other muscles. Muscle edema
was determined on inversion recovery or T2-weighted images as areas of
increased signal within the muscle compared with other muscles. Masslike
lesions were defined as discrete regions in the subcutaneous or muscle
compartments with morphology and signal intensity differing from the
surrounding tissue [20].
Soft-tissue infiltration was defined as discrete noncircumferential
reticulation and/or nodularity of altered signal compared with the surrounding
tissue in that compartment. A subject having multiple areas scanned with
positive findings on any single study was considered a positive case. Two
cases with overlapping findings (small bone lesions and arthritis) were
categorized by the more dominant lesion and included as a subset of bone
lesions.
Radiographs of the symptomatic area were obtained for 17 patients, and for
three patients with lesions of the head, CT was obtained for evaluation of the
skull. All but two patients with bone lesions had radiographs or CT scans. We
did not correlate radiographs with MR images for patients with soft-tissue
lesions. The radiographs and CT scans (or reported interpretations for three
cases without radiographs available for review) were correlated with the MRI
findings by consensus by the two radiologists. All abnormal findings detected
on either technique were compared for size, location, and extent and scored as
equivalent, more or less conspicuous or extensive, or detected on one
technique and not the other.
Biopsy was recommended for all of the patients with large-bone and
soft-tissue lesions, including masses, muscle lesions, myopathy, and
subcutaneous reticulation. Biopsy was not recommended for patients with hand
and foot lesions or joint findings except one patient with massive
tenosynovitis. The final decision for or against biopsy was determined by the
clinicians. Four patients declined recommended biopsy. Biopsy evaluation of
the musculoskeletal lesions showed at MRI was obtained for 17 of the subjects
(49% of the patients with positive MRI findings). Biopsy findings were counted
positive for sarcoidosis if reported as noncaseating granulomas in the absence
of other causes of granulomatous disease. Seventeen biopsies were performed
(nine of bone, four of muscle, two of masses, one of tenosynovium, and one of
subcutaneous reticulation).

View larger version (168K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A 58-year-old woman with sarcoidosis and pelvic pain.
Anteroposterior radiograph of pelvis was interpreted as normal. Coronal images
of pelvis and hips obtained with T1-weighting (TR/TE 550/8) in A, and
proton density weighting with fat saturation in B (3,600/22) show
innumerable discrete subcentimeric lesions infiltrating marrow.
|
|

View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B 58-year-old woman with sarcoidosis and pelvic pain.
Anteroposterior radiograph of pelvis was interpreted as normal. Coronal images
of pelvis and hips obtained with T1-weighting (TR/TE 550/8) in A, and
proton density weighting with fat saturation in B (3,600/22) show
innumerable discrete subcentimeric lesions infiltrating marrow.
|
|

View larger version (165K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2C 58-year-old woman with sarcoidosis and pelvic pain.
Anteroposterior radiograph of pelvis was interpreted as normal. Coronal detail
of sacrum, coronal proton density fat-saturated (TR/TE 3,600/22) image shows
innumerable high-signal discretely marginated round lesions, most 1 cm or
smaller. Although patient had sarcoidosis and no known primary tumor, clinical
assumption was metastases and patient underwent deep bone biopsy that revealed
noncaseating granulomas.
|
|

View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3 55-year-old woman with hip pain. T1-weighted axial image
(TR/TE 550/9) obtained through upper pelvis. Low signal lesion in left ilium
does not violate cortex (black arrow). Apparent asymmetry of iliac
bones is due to positioning.
|
|

View larger version (102K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4 52-year-old woman with wrist "mass." T1-weighted
(TR/TE 500/10) axial image performed with fat saturation after administration
of IV gadolinium chelate shows tenosynovitis of extensor compartment with
marked thickening and enhancement of synovium. Synovial biopsy showed
noncaseating granulomas.
|
|
As there was a relatively high prevalence of bone lesions in the study
population, two-sided cross-tabulations were performed for associations
between the clinical findings of the subgroup of study patients with bone
lesions on MRI (except AVN) as compared with all other study subjects, using
Fisher's exact test.

View larger version (83K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5 55-year-old woman with sarcoidosis and leg weakness. Patient
was treated with steroids. Coronal T1-weighted image (TR/TE 550/8) shows fatty
replacement of right gluteal and bilateral hamstring muscles. Biopsy of
gastrocnemius muscle showed noncaseating granulomas.
|
|

View larger version (126K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6A 51-year-old woman with painful palpable calf nodules.
T1-weighted axial image of right calf (TR/TE 550/9) shows donut-shaped lesion,
nearly isointense with muscle, with low signal intensity centrally (white
arrow).
|
|

View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6B 51-year-old woman with painful palpable calf nodules.
T2-weighted axial image (4,550/54), same level. Lesion showed mild increase in
signal intensity compared with surrounding muscle, with low signal intensity
centrally but not as bright as fluid (white arrow).
|
|

View larger version (108K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6C 51-year-old woman with painful palpable calf nodules.
T1-weighted axial image (616/9) with fat saturation after IV administration of
gadopentetate dimeglumine. Periphery of lesion enhances (white
arrow), but central "dark star" does not.
|
|
Results
Bone Lesions
In 17 subjects, MRI showed intramedullary lesions ranging in size from <
1 to 3-4 cm. Of four cases involving the small bones, two showed cortical
destruction/periosseous extension. Thirteen patients showed lesions on MRI of
the large bones or axial skeleton. These were seen in the pelvis (five
lesions), calvarium (two lesions), radius (one lesion), scapula (one lesion),
humeral head (one lesion), femur (one lesion), tibia/calcaneus (one lesion),
and ulna (one lesion). Nine of the large-bone cases showed multiple lesions,
and four were solitary lesions. In four patients, the large-bone lesions were
diffuse and indistinctly marginated (Fig.
1), and in nine the lesions were discretely marginated (Figs.
2A,
2B,
2C). In some cases, such as
Figs. 2A,
2B,
2C, background red marrow was
noted but the morphology or location of the lesions usually allowed reasonable
differentiation from red marrow. With large-bone lesions, no cortical
destruction was observed (Fig.
3). Two additional patients (5%) with MRI findings of hip AVN had
undergone corticosteroid treatment.
Joint Abnormalities
Nine patients had joint abnormalities on MRI, all with negative serology
for ANA and rheumatoid factor. Only one patient underwent synovial biopsy,
which showed noncaseating granulomas (Fig.
4).
Muscle Lesions
Two patients showed fatty replacement of the thigh muscles
(Fig. 5). One patient showed
muscle edema in the thigh adductors, which enhanced. Gastrocnemius biopsies in
these three cases showed noncaseating granulomas. The fourth patient had
tender, palpable calf nodules manifesting as discrete intramuscular nodules on
MRI (Figs. 6A,
6B,
6C), with an appearance
characteristic of nodular sarcoidosis of muscle
[14,
15] confirmed on biopsy.
Three patients showed soft-tissue mass lesions on MRI. One mass had MRI
characteristics of a simple lipoma. Two patients showed masses with mixed
signal characteristics. Biopsy revealed infarcted lipoma and noncaseating
granulomas, respectively. In two cases, subcutaneous soft-tissue reticulation
(more focal than typically seen with edema) was seen in the legs, decreased in
signal intensity on T1, and bright on water-sensitive sequences. In one of
these cases, biopsy showed noncaseating granulomas.
The associations of the MRI findings with chest radiograph stage,
multiorgan and skin involvement, and biopsy findings are presented in
Table 2. No statistically
significant differences between subjects with or without marrow lesions on MRI
were found for the parameters examined: skin lesions (p = 0.8), chest
radiograph stage (p = 0.15), disease duration equal to or less than 2
years (p = 0.5), elevated alkaline phosphatase, calcium, or
angiotensin-converting enzyme (p = 0.16), multiorgan disease (three
or more organs) (p = 0.3), sex (p = 0.3), or race
(p = 0.7). However, within the study population, those with bone
lesions differed from those without bone lesions, showing a higher prevalence
of stage I or II chest radiograph abnormality (76% with bone lesions, 52% all
others), multiorgan involvement (41% with bone lesions, 26% all others),
elevated alkaline phosphatase, ACE, and/or serum calcium (53% with bone
lesions, 35% all others). The prevalence of skin lesions differed little
between these groups, as 6/17 (35%) of patients with and 9/23 (39%) without
bone lesions had skin lesions. There were no statistically significant
differences in duration since sarcoidosis diagnosis between the two
groups.
View this table:
[in this window]
[in a new window]
|
TABLE 2 : Association of MRI, Clinical, and Biopsy Findings in 40 Patients with
Sarcoidosis and Musculoskeletal Complaints
|
|
MRI/Radiographic and CT Correlation
Eleven of the 20 cases reviewed showed comparable or equivalent MRI and
radiographic or CT findings. Of the remaining nine subjects, six with bone
lesions on MRI had normal radiographs and three had radiographic or CT
findings less conspicuous/extensive than bone lesions detected on MRI. The
association of intramedullary lesions on MR images with a negative radiograph
was most often noted with large-bone lesions (n = 5).
Discussion
This study shows the utility of MRI to detect and delineate lesions in
patients with sarcoidosis with musculoskeletal signs and symptoms. Our study
detected a large range of musculoskeletal lesions of biopsy-proven sarcoidal,
nonsarcoidal (e.g., infarcted lipoma), and histologically undetermined cause
that may be encountered in the MRI investigation of musculoskeletal complaints
in sarcoidosis patients.
In our study, MRI revealed more axial skeleton and large-bone disease than
had been recognized on standard films. Using standard musculoskeletal
protocols, the MRI appearance of these lesions is not specific and should be
differentiated from metastatic disease, multiple myeloma, lymphoma, osseous
hemangioma, and disseminated granulomatous infection
[3,
17]. In no large-bone lesion
was there MRI evidence of cortical destruction, although cortical disruption
and extraosseous extension were seen with small-bone lesions. The lack of
cortical destruction with large-bone lesions might explain why these lesions
were radiographically occult. We do not consider MRI necessary in most cases
for the diagnosis of sarcoidal lesions of the small bones of the hand and feet
(in proven sarcoidosis patients), as the radiographic finding of lacy
osteolysis of the small bones of the hands and feet is virtually pathognomonic
in the setting of clinical sarcoidosis.
The joint abnormalities detected on MRI reflect nonspecific arthropathy of
indeterminate origin, which could include common arthritides such as
degenerative disease. Whether sarcoidal arthropathy may have contributed to
some of the findings is speculative. Histologic evaluation is not routinely
performed to differentiate possible sarcoidal arthropathy from other causes of
joint pathology, and the diagnosis of sarcoidosis arthritis is usually based
on clinical presentation rather than imaging. Only in one case did joint
findings at MRI (tenosynovitis) lead to biopsy. All of the patients with joint
abnormalities on MRI had normal rheumatoid factor and ANA laboratory
values.
The MRI finding of fatty atrophy of the muscles can be seen with
sarcoidosis myopathy and other muscle disorders including corticosteroid
myopathy, residua of trauma, chronic disuse, and/or chronic denervation
[20]. Differentiation of
sarcoidosis myopathy from other myopathies requires correlation with
electromyography, which shows greater muscle irritability with sarcoidal
myopathy than steroid myopathy. Creatine kinase levels are often elevated in
muscle sarcoidosis but not corticosteroid myopathy. MRI does not differentiate
between these causes but can be used to assess the degree of atrophy and guide
the selection of a muscle biopsy site, obviating a biopsy of fatty-replaced
muscle.
The MRI findings of musculoskeletal sarcoidosis lesions may reveal systemic
involvement and a greater burden of granulomas than had been previously
considered, which may have therapeutic and prognostic significance. When
musculoskeletal manifestations are detected, MRI can also guide biopsy in
patients with suspected but unproven sarcoidosis and can be used to follow
response to treatment.
The higher prevalence of multiorgan disease and chest radiograph
abnormality corresponding to Scadding stage I or II among sarcoidosis patients
with bone lesions on MRI suggests a correlation of bone lesions with
lymphadenopathy and total body granulomatous burden. Although cutaneous
sarcoidosis lesions have been reported as associated with skeletal lesions
[21], we did not find a
statistically significant correlation in our study population.
Our study has several recognized limitations. It did not include a
comparison group of sarcoidosis patients without osteoarticular symptoms nor
patients without sarcoidosis. The clinicians referred only patients with
musculoskeletal symptoms, which probably led to the relatively large
percentage of cases with positive MRI findings. Thus, the frequency of lesion
type detected cannot be generalized to the sarcoidosis population at large.
Fewer than half the subjects underwent biopsy evaluation of the
musculoskeletal abnormality, and the potential sarcoidal cause of the
nonbiopsied abnormalities detected at MRI was not determined. The comparison
of radiograph and MRI findings was limited by the unavailability of
correlative radiographs for some cases. We scanned only the area of signs
and/or symptoms; further work is needed to assess the extent of involvement in
asymptomatic regions in this patient population. Some of the patients had
background changes of red marrow replacement in the pelvis and spine, which
made distinguishing their marrow lesions more difficult. Dedicated sequences
such as opposed phase gradient-echo sequences might be more accurate for
distinguishing hematopoietic from pathologic marrow.
In evaluating sarcoidosis patients with musculoskeletal symptoms, MRI
detects radiographically silent disease in the soft tissues and large bones.
With the standard technique, in most cases, no pathognomonic imaging findings
allow differentiation from other pathologies, including neoplasm.
The clinician should consider MRI for the evaluation of sarcoidosis
patients with unexplained osteoarticular complaints if standard radiographs
are negative. Radiologists should include sarcoidosis in the differential
diagnosis of musculoskeletal disease detected at MRI in the appropriate
clinical setting and should be alerted that large-bone and axial skeleton
sarcoidosis lesions encountered on MRI might resemble metastatic lesions.
References
- Bushara KO, Petermann G, Waclawik AJ, Brown WD, Schutta HS.
Sarcoidosis of the spinal cord with extensive vertebral involvement: a case
report. Comput Med Imaging Graph1995; 19:443
-446[CrossRef][Medline]
- Fisher AJ, Gilula LA, Kyriakos M, Holzaepfel. MR imaging changes of
lumbar vertebral sarcoidosis. AJR1999; 173:354
-356[Free Full Text]
- Ginsberg LE, Williams DW, Stanton D. MRI of vertebral sarcoidosis.
J Comput Assist Tomogr1993; 17:158
-159[Medline]
- Golzarian J, Matos C, Golstein M, Stallenberg B, Depierreux M,
Struyven J. Case report: osteosclerotic sarcoidosis of spine and pelvis: plain
film and magnetic resonance imaging findings. Br J
Radiol 1994;67:401
-404[Abstract/Free Full Text]
- Kenney CM III, Goldstein ST. MRI of sarcoidosis spondylolisthesis.
J Comput Assist Tomogr1992; 16:660
-662[Medline]
- Poyanli A, Poyanli O, Sencer S, Akan K, Sayrak H, Acunas B.
Vertebral sarcoidosis: imaging findings. Eur Radiol2000; 10:92
-94[CrossRef][Medline]
- Sundaram M, Place H, Shaffer WO, Martin DS. Progressive destructive
vertebral sarcoid leading to surgical fusion. Skeletal
Radiol 1999;28:717
-722[CrossRef][Medline]
- Beasley EW III, Peterman SB, Hertzler GL. An unusual form of tibial
sarcoidosis. AJR1987; 149:754
-756[Free Full Text]
- Blacksin MF, Acello AN, Kowalc J, Lyons MM. Osseous sarcoidosis of
the foot: detection by MR imaging. AJR1994; 163:1444
-1445[Free Full Text]
- Blank NM, Steininger H, Kalden JR, Burkhardt H. Symptomatic bone
lesion of the tibia head as onset manifestation of sarcoid. J
Rheumatol 1999;26:936
-937[Medline]
- Ferrozzi F, Folegnani F, Delnevo D, Campani R. Tibial sarcoidosis.
Radiologic and magnetic resonance aspects. Radiol Med
(Torino) 1997;94:675
-677[Medline]
- Powers TA, Limbird TJ. MRI of the knee in sarcoidosis: synovial and
marrow involvement. J Comput Assist Tomogr1994; 18:313
-314[Medline]
- Rayner CK, Burnet SP, McNeil JD. Osseous sarcoidosisa
magnetic resonance imaging diagnosis. Clin Exp
Rheumatol 2002;20:546
-548[Medline]
- Otake S, Ishigaki T. Muscular sarcoidosis. Semin
Musculoskelet Radiol 2001;5:167
-170[CrossRef][Medline]
- Otake S. Sarcoidosis involving skeletal muscle: imaging findings
and relative value of imaging procedures. AJR1994; 162:369
-375[Abstract/Free Full Text]
- Resnick D. Sarcoidosis. In: Resnick D, ed. Diagnosis of
bone and joint disorders, 4th ed. Philadelphia, PA: Saunders,2002
: 4771-4791
- Milman N, Lund JO, Graudal N, Enevoldsen H, Evald T, Norgard P.
Diagnostic value of routine radioisotope bone scanning in a series of 63
patients with pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung
Dis 2000;17:67
-70[Medline]
- Mitchell DN, Scadding JG. Sarcoidosis. Am Rev Respir
Dis 1974;110:774
-802[Medline]
- Mitchell DG, Rao VM, Dalinka MK, et al. Femoral head avascular
necrosis: correlation of MR imaging, radiographic staging, radionuclide
imaging, and clinical findings. Radiology1987; 162:709
-715[Abstract/Free Full Text]
- May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ. Abnormal
signal intensity in skeletal muscle at MR imaging: patterns, pearls, and
pitfalls. RadioGraphics2000; 20[Spec No]:S295
-S315. Review[Abstract/Free Full Text]
- Funk SD, Kremer JM. Cutaneous and musculoskeletal features,
diagnostic modalities, and immunopathology in sarcoidosis. Curr
Opin Rheumatol 1994;6:78
-81[Medline]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. B. Prabhakar, C. B. Rabinowitz, and F. S. Chew
Imaging of sarcoidosis: self-assessment module.
Am. J. Roentgenol.,
March 1, 2008;
190(3 Suppl):
S7 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|